CINI JOHN K. (Chief Scientific Officer) received a stock award from SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2023ACC: 0001493152-23-005465
Officer· Chief Scientific Officer
Since Apr 2020
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18.55K acquired · 18.55K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−18.55K
Price / share
—
Trade value
—
% of position
46.1%
1/7/2023
40.27K→21.72K
Common Stock
Direct
Shares
+18.55K
Price / share
—
Trade value
—
% of position
85.4%
1/7/2023
21.72K→40.27K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2023 | D · Disposition | −18.55K | — | — | 46.1% | 40.27K | 21.72K |
| Common Stock Direct | 1/7/2023 | A · Award | +18.55K | — | — | 85.4% | 21.72K | 40.27K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported